• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾功能正常的极度肥胖患者的肾损伤。

Renal injury in the extremely obese patients with normal renal function.

作者信息

Serra A, Romero R, Lopez D, Navarro M, Esteve A, Perez N, Alastrue A, Ariza A

机构信息

Department of Nephrology, Hospital Universitari Germans Trias i Pujol, Autonomous University of Barcelona, Badalona, Barcelona, Spain.

出版信息

Kidney Int. 2008 Apr;73(8):947-55. doi: 10.1038/sj.ki.5002796. Epub 2008 Jan 23.

DOI:10.1038/sj.ki.5002796
PMID:18216780
Abstract

We studied the glomerular architecture in renal biopsies of 95 patients undergoing bariatric surgery for extreme obesity but whose renal function was normal. The comparison group was 40 control patients having protocol biopsies. These latter patients had normal weight and renal function, were non-diabetic, non-hypertensive, and were undergoing nephrectomy or donating a kidney. Logistic regression models determined associations between the clinical and biochemical variables and glomerular lesions. Arterial hypertension, sleep apnea syndrome (SAS), and microalbuminuria were prevalent in the obese patients, as was hyperglycemia to a lesser extent. Focal and segmental glomerulosclerosis was present in only five extremely obese (EO) patients but absent in controls. Increased mesangial matrix, podocyte hypertrophy, mesangial cell proliferation, and glomerulomegaly were more frequent in the obese cohort than in the control group. Body mass index was a significant independent risk factor associated with glomerular lesions in all 135 patients and in the 95 EO patients, whereas SAS was associated with glomerulomegaly only in the EO. Our study shows that EO patients who lack overt clinical renal symptoms have a variety of glomerular abnormalities that correlate with body mass.

摘要

我们研究了95例接受减肥手术治疗极度肥胖但肾功能正常患者的肾活检肾小球结构。对照组为40例接受方案活检的对照患者。后一组患者体重和肾功能正常,无糖尿病、高血压,正在接受肾切除术或捐献肾脏。逻辑回归模型确定了临床和生化变量与肾小球病变之间的关联。动脉高血压、睡眠呼吸暂停综合征(SAS)和微量白蛋白尿在肥胖患者中很常见,高血糖在较小程度上也很常见。仅5例极度肥胖(EO)患者存在局灶节段性肾小球硬化,而对照组中未发现。肥胖队列中系膜基质增加、足细胞肥大、系膜细胞增殖和肾小球肿大比对照组更常见。体重指数是所有135例患者和95例EO患者中与肾小球病变相关的显著独立危险因素,而SAS仅在EO患者中与肾小球肿大相关。我们的研究表明,缺乏明显临床肾脏症状的EO患者存在多种与体重相关的肾小球异常。

相似文献

1
Renal injury in the extremely obese patients with normal renal function.肾功能正常的极度肥胖患者的肾损伤。
Kidney Int. 2008 Apr;73(8):947-55. doi: 10.1038/sj.ki.5002796. Epub 2008 Jan 23.
2
Low Insulin-Like Growth Factor-1 Level in Obesity Nephropathy: A New Risk Factor?肥胖相关性肾病中低胰岛素样生长因子-1水平:一种新的危险因素?
PLoS One. 2016 May 3;11(5):e0154451. doi: 10.1371/journal.pone.0154451. eCollection 2016.
3
Effect of drastic weight loss after bariatric surgery on renal parameters in extremely obese patients: long-term follow-up.减肥手术后大幅体重减轻对极度肥胖患者肾脏参数的影响:长期随访
J Am Soc Nephrol. 2006 Dec;17(12 Suppl 3):S213-7. doi: 10.1681/ASN.2006080917.
4
Early histological changes in the kidney of people with morbid obesity.病态肥胖患者肾脏的早期组织学变化。
Nephrol Dial Transplant. 2009 Dec;24(12):3732-8. doi: 10.1093/ndt/gfp329. Epub 2009 Jul 13.
5
Determinants of focal and segmental glomerulosclerosis in the rat after renal ablation. Evidence for involvement of macrophages and lipids.肾切除术后大鼠局灶节段性肾小球硬化的决定因素。巨噬细胞和脂质参与的证据。
Lab Invest. 1991 Jun;64(6):754-65.
6
Early events leading to renal injury in obese Zucker (fatty) rats with type II diabetes.导致伴有II型糖尿病的肥胖 Zucker(脂肪)大鼠肾损伤的早期事件。
Kidney Int. 2000 Jan;57(1):167-82. doi: 10.1046/j.1523-1755.2000.00836.x.
7
Effect of ramipril, nifedipine, and moxonidine on glomerular morphology and podocyte structure in experimental renal failure.雷米普利、硝苯地平和莫索尼定对实验性肾衰竭肾小球形态和足细胞结构的影响。
Nephrol Dial Transplant. 1996 Jun;11(6):1003-11.
8
Supersized kidneys: Lessons from the preclinical obese kidney.超大肾脏:临床前肥胖肾脏的经验教训。
Kidney Int. 2008 Apr;73(8):909-10. doi: 10.1038/ki.2008.42.
9
Clinicopathological characteristics of obesity-associated focal segmental glomerulosclerosis.肥胖相关性局灶节段性肾小球硬化的临床病理特征
Ultrastruct Pathol. 2011 Aug;35(4):176-82. doi: 10.3109/01913123.2011.584657. Epub 2011 Jun 9.
10
In-hospital outcomes of percutaneous coronary interventions in extremely obese and normal-weight patients: findings from the NCDR (National Cardiovascular Data Registry).极度肥胖和正常体重患者经皮冠状动脉介入治疗的院内转归:来自 NCDR(国家心血管数据注册)的研究结果。
J Am Coll Cardiol. 2013 Aug 20;62(8):692-6. doi: 10.1016/j.jacc.2013.05.058.

引用本文的文献

1
Obesity-Related Glomerulosclerosis-How Adiposity Damages the Kidneys.肥胖相关肾小球硬化症——肥胖如何损害肾脏
Int J Mol Sci. 2025 Jun 28;26(13):6247. doi: 10.3390/ijms26136247.
2
The Role of miRNAs as Early Biomarkers in Obesity-Related Glomerulopathy: Implications for Early Detection and Treatment.微小RNA作为肥胖相关性肾小球病早期生物标志物的作用:对早期检测和治疗的意义
Biomedicines. 2025 Apr 24;13(5):1030. doi: 10.3390/biomedicines13051030.
3
Obesity-related glomerulopathy: How it happens and future perspectives.肥胖相关性肾小球病:发病机制及未来展望
Diabet Med. 2025 Jun;42(6):e70042. doi: 10.1111/dme.70042. Epub 2025 Apr 14.
4
Obesity and Metabolic Health in CKD.慢性肾脏病中的肥胖与代谢健康
Clin J Am Soc Nephrol. 2025 May 1;20(5):742-754. doi: 10.2215/CJN.0000000704. Epub 2025 Mar 14.
5
Time-restricted feeding reduces cardiovascular disease risk in obese mice.限时进食可降低肥胖小鼠患心血管疾病的风险。
JCI Insight. 2025 Jan 7;10(4):e160257. doi: 10.1172/jci.insight.160257.
6
Kidney consequences of obesity.肥胖对肾脏的影响
Pediatr Nephrol. 2025 Jun;40(6):1879-1893. doi: 10.1007/s00467-024-06623-y. Epub 2024 Dec 16.
7
Clinical Impact of Obesity on Postoperative Outcomes of Patients With Thyroid Cancer Undergoing Thyroidectomy: A 5-Year Retrospective Analysis From the US National Inpatient Sample.肥胖对甲状腺癌患者甲状腺切除术术后结局的临床影响:来自美国国家住院患者样本的 5 年回顾性分析。
Cancer Med. 2024 Oct;13(19):e70335. doi: 10.1002/cam4.70335.
8
The renal histopathology of nonproteinuric kidney impairment: a three center experience.非蛋白尿性肾功能损害的肾脏组织病理学:三中心经验。
Clin Exp Med. 2024 Oct 3;24(1):236. doi: 10.1007/s10238-024-01494-x.
9
New Perspectives on Obesity-Associated Nephropathy from Pathophysiology to Therapeutics: Revealing the Promise of GLP-1 RA Therapy.从病理生理学到治疗学:肥胖相关性肾病的新视角——揭示 GLP-1RA 治疗的前景。
Drug Des Devel Ther. 2024 Sep 23;18:4257-4272. doi: 10.2147/DDDT.S476815. eCollection 2024.
10
The Kidney in Obesity: Current Evidence, Perspectives and Controversies.肥胖与肾脏:现有证据、观点与争议
Curr Obes Rep. 2024 Dec;13(4):680-702. doi: 10.1007/s13679-024-00583-y. Epub 2024 Aug 14.